上海cmc培训 post approval changes for finished product

上海cmc培训 post approval changes for finished product

ID:40121591

大小:117.00 KB

页数:20页

时间:2019-07-22

上海cmc培训 post approval changes for finished product_第1页
上海cmc培训 post approval changes for finished product_第2页
上海cmc培训 post approval changes for finished product_第3页
上海cmc培训 post approval changes for finished product_第4页
上海cmc培训 post approval changes for finished product_第5页
资源描述:

《上海cmc培训 post approval changes for finished product》由会员上传分享,免费在线阅读,更多相关内容在教育资源-天天文库

1、PostApprovalChangesforFinishedProductLinHong1AAPS/CPAWorkshop,June28-29,2010DisclaimerTheinformationcontainedinthepresentationhasbeencompiledfromvarioussources.Theviewsandopinionsexpressedarethoseoftheindividualpresenterandshouldnotbeattributedtoanyorganiza

2、tionwithwhichthepresenterisemployedoraffiliated.2AAPS/CPAWorkshop,June28-29,2010PostApprovalChangesGuidelineDocumentsUS:SUPAC:IR(1995),MR(1997)SUPAC:IR/MREquipmentGuidance(1999)SUPAC:ExtendedreleaseOralSolidDosageForms,Development,EvaluationandApplicationof

3、In-Vitro/In-VivoCorrelation(1997)ChangestoanApprovedNDAorANDA(2004)3AAPS/CPAWorkshop,June28-29,2010PostApprovalChangesGuidelineDocumentsEU:CommissionRegulation(EC)No726/2004CommissionRegulation(EC)No1234/2008CommissionRegulation(EC)No1084(5)/2003ModifiedRel

4、easeOralandTransdermalDosageForms:SectionsIandIICPMP/QWP/604/96,CPMP/EWP/280/96GuidelineontheInvestigationofBioequivalenceCPMP/EWP/QWP/1401/984AAPS/CPAWorkshop,June28-29,2010UnitedStatesTheguidelinesprovidedetailsofthe…TypeofchangeLevelsofchangeCMCdocumenta

5、tionrequiredtosupportthechange(dissolutionand/orbioequivalencetests,analyticaltesting….)Filingrequirements5AAPS/CPAWorkshop,June28-29,2010UnitedStatesMinorChange(Level1):MinimalpotentialtohaveanadverseeffectAnnualreport(AR)ModerateChange(Level2):Moderatepot

6、entialtohaveanadverseeffectChangesBeingEffected(CBE)ChangesBeingEffected30days(CBE-30)MajorChange(Level3):SubstantialpotentialtohaveanadverseeffectPriorApprovalSupplement(PAS)6AAPS/CPAWorkshop,June28-29,2010UnitedStatesToIndustry:Responsibilitytoclassifycha

7、ngemovedfromFDAtoindustryAllowsmorechangeswithoutpriorFDAapprovalUseofnewtechnologiesManufacturingcostreductionAdequacyofthestudiesmaybequestionedmonthsoryearslaterevenifthechangesarepredictedorapprovedIfthevalidityofAR/CBE/CBE-30changesischallengedthespons

8、ormayberequiredtotracktheaffectedlots/batchesandprovideadditionaldata,quarantineorrecallproductifitisneededGreaterliabilityifthechangeisnotadequatelysupported7AAPS/CPAWorkshop,June28-29,2010EuropeanUni

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。